3.75
price up icon7.45%   0.26
pre-market  시장 영업 전:  3.84   0.09   +2.40%
loading

Abcellera Biologics Inc 주식(ABCL)의 최신 뉴스

pulisher
Jun 13, 2025

AbCellera shareholders approve board election and auditor - Investing.com Australia

Jun 13, 2025
pulisher
Jun 13, 2025

AbCellera shareholders approve board election and auditor By Investing.com - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

AbCellera Biologics Holds Annual Shareholder Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

AbCellera Biologics: The Dilemma Of A Promising Pipeline Alongside Cash Burn (ABCL) - Seeking Alpha

Jun 13, 2025
pulisher
Jun 12, 2025

ABCELLERA BIOLG (ABCL) Upgraded to Buy: Here's Why - MSN

Jun 12, 2025
pulisher
Jun 11, 2025

AbCellera Biologics (ABCL) Stands Out in Active Option Classes | - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

AbCellera Biologics (ABCL) Stands Out in Active Option Classes | ABCL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 09, 2025

AbCellera Biologics Inc. (ABCL): A Bull Case Theory - MSN

Jun 09, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Acquires 44,367 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) - Defense World

Jun 09, 2025
pulisher
Jun 03, 2025

AbCellera Biologics Inc. (ABCL) Approved to Begin ABCL575 Trial for Atopic Dermatitis - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

AbCellera Biologics And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

Jun 03, 2025
pulisher
Jun 02, 2025

Why AbCellera Biologics Stock Raced Nearly 6% Higher Today - AOL.com

Jun 02, 2025
pulisher
Jun 02, 2025

AbCellera (ABCL) Stock Rises on Health Canada Approval - GuruFocus

Jun 02, 2025
pulisher
May 31, 2025

AbCellera gains Health Canada nod for AD antibody trial By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575 - BioSpace

May 30, 2025
pulisher
May 30, 2025

AbCellera (ABCL) Gains Health Canada Approval for Clinical Trial - GuruFocus

May 30, 2025
pulisher
May 30, 2025

AbCellera Biologics Receives Health Canada Approval for Trial - TipRanks

May 30, 2025
pulisher
May 30, 2025

AbCellera Biologics Gets Health Canada Authorization for Phase 1 Trial of Dermatitis Treatment - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

AbCellera Receives Authorization from Health Canada to Initiate - GuruFocus

May 30, 2025
pulisher
May 30, 2025

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575 | ABCL Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

AbCellera receives Health Canada authorization to initiate ABCL575 Phase 1 trial - TipRanks

May 30, 2025
pulisher
May 30, 2025

AbCellera gains Health Canada nod for AD antibody trial - Investing.com

May 30, 2025
pulisher
May 30, 2025

Health Canada Greenlights AbCellera's Novel Antibody Trial for Chronic Skin Disease Treatment - Stock Titan

May 30, 2025
pulisher
May 30, 2025

AbCellera Biologics Inc. (NASDAQ:ABCL) Stock Holdings Boosted by Millennium Management LLC - Defense World

May 30, 2025
pulisher
May 30, 2025

AbCellera Biologics Inc. (ABCL): Analysts See 474% Upside Potential - MSN

May 30, 2025
pulisher
May 29, 2025

AbCellera Biologics Inc. raises US$100M in series A2 financing - McCarthy Tétrault

May 29, 2025
pulisher
May 20, 2025

13 Best Multibagger Stocks to Invest in Now - Insider Monkey

May 20, 2025
pulisher
May 18, 2025

Truist Financial Has Lowered Expectations for AbCellera Biologics (NASDAQ:ABCL) Stock Price - Defense World

May 18, 2025
pulisher
May 16, 2025

Truist cuts AbCellera stock target to $10, maintains Buy By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

Truist Securities Lowers Price Target for AbCellera Biologics (A - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Truist cuts AbCellera stock target to $10, maintains Buy - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

Truist Securities Lowers Price Target for AbCellera Biologics (ABCL) | ABCL Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Truist Adjusts Price Target for AbCellera (ABCL) Amid Strategic Shift | ABCL Stock News - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Abcellera gains Canadian clearance for phase I study of ABCL-635 for vasomotor symptoms in menopause - BioWorld MedTech

May 15, 2025
pulisher
May 15, 2025

Some Analysts Just Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates - simplywall.st

May 15, 2025
pulisher
May 15, 2025

Analyst Forecasts Just Became More Bearish On AbCellera Biologics Inc. (NASDAQ:ABCL) - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

AbCellera to begin Phase 1 trial for menopause treatment By Investing.com - Investing.com Nigeria

May 15, 2025
pulisher
May 14, 2025

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause - BioSpace

May 14, 2025
pulisher
May 14, 2025

AbCellera Biologics Gets Health Canada Approval for Phase 1 Trial of Menopause Treatment - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

AbCellera to begin Phase 1 trial for menopause treatment - Investing.com

May 14, 2025
pulisher
May 14, 2025

AbCellera (ABCL) Set to Launch Clinical Trial for Menopause Trea - GuruFocus

May 14, 2025
pulisher
May 14, 2025

AbCellera (ABCL) Set to Launch Clinical Trial for Menopause Treatment | ABCL Stock News - GuruFocus

May 14, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):